Anetumab ravtansine: a novel mesothelin-targeting antibody-drug conjugate cures tumors with heterogeneous target expression favored by bystander effect (Q39006265)
Jump to navigation
Jump to search
scientific article published on 8 April 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Anetumab ravtansine: a novel mesothelin-targeting antibody-drug conjugate cures tumors with heterogeneous target expression favored by bystander effect |
scientific article published on 8 April 2014 |
Statements
1 reference
Anetumab ravtansine: a novel mesothelin-targeting antibody-drug conjugate cures tumors with heterogeneous target expression favored by bystander effect (English)
1 reference
Sven Golfier
1 reference
Charlotte Kopitz
1 reference
Antje Kahnert
1 reference
Iring Heisler
1 reference
Christoph A Schatz
1 reference
Beatrix Stelte-Ludwig
1 reference
Anke Mayer-Bartschmid
1 reference
Kerstin Unterschemmann
1 reference
Sandra Bruder
1 reference
Lars Linden
1 reference
Axel Harrenga
1 reference
Peter Hauff
1 reference
Frank-Detlef Scholle
1 reference
Beate Müller-Tiemann
1 reference
Bertolt Kreft
1 reference
Karl Ziegelbauer
1 reference
8 April 2014
1 reference
1 reference
13
1 reference
6
1 reference
1537-1548
1 reference
Identifiers
1 reference
1 reference